- Home
- ALLE vs ASND Comparison
ALLE vs ASND Comparison
Compare ALLE & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- ASND
- Stock Information
- Founded
- ALLE 2013
- ASND 2006
- Country
- ALLE Ireland
- ASND Denmark
- Employees
- ALLE N/A
- ASND N/A
- Industry
- ALLE Diversified Commercial Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ALLE Consumer Discretionary
- ASND Health Care
- Exchange
- ALLE Nasdaq
- ASND Nasdaq
- Market Cap
- ALLE 14.9B
- ASND 12.0B
- IPO Year
- ALLE N/A
- ASND 2015
- Fundamental
- Price
- ALLE $177.39
- ASND $210.83
- Analyst Decision
- ALLE Hold
- ASND Strong Buy
- Analyst Count
- ALLE 9
- ASND 16
- Target Price
- ALLE $170.33
- ASND $240.75
- AVG Volume (30 Days)
- ALLE 933.4K
- ASND 406.9K
- Earning Date
- ALLE 10-23-2025
- ASND 11-13-2025
- Dividend Yield
- ALLE 1.15%
- ASND N/A
- EPS Growth
- ALLE 14.50
- ASND N/A
- EPS
- ALLE 7.20
- ASND N/A
- Revenue
- ALLE $3,876,600,000.00
- ASND $576,332,355.00
- Revenue This Year
- ALLE $9.19
- ASND $102.31
- Revenue Next Year
- ALLE $5.80
- ASND $76.44
- P/E Ratio
- ALLE $24.64
- ASND N/A
- Revenue Growth
- ALLE 5.49
- ASND 54.50
- 52 Week Low
- ALLE $116.57
- ASND $118.03
- 52 Week High
- ALLE $180.34
- ASND $214.71
- Technical
- Relative Strength Index (RSI)
- ALLE 58.86
- ASND 67.02
- Support Level
- ALLE $175.26
- ASND $187.25
- Resistance Level
- ALLE $179.56
- ASND $205.48
- Average True Range (ATR)
- ALLE 2.70
- ASND 5.98
- MACD
- ALLE -0.32
- ASND 1.02
- Stochastic Oscillator
- ALLE 61.54
- ASND 85.87
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.